ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $294,077 | +3.4% | 8,162 | +13.4% | 0.12% | -0.8% |
| Q4 2022 | $284,386 | +1.6% | 7,196 | +3.4% | 0.12% | -8.9% |
| Q3 2022 | $280,000 | +2.6% | 6,962 | +7.1% | 0.14% | +3.1% |
| Q2 2022 | $273,000 | +5.0% | 6,502 | -2.8% | 0.13% | +23.6% |
| Q1 2022 | $260,000 | +6.6% | 6,686 | +9.2% | 0.11% | +8.2% |
| Q4 2021 | $244,000 | +15.1% | 6,122 | +4.6% | 0.10% | +2.1% |
| Q3 2021 | $212,000 | – | 5,853 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |